Literature DB >> 25987010

Types of Cancers Prevailing in Pakistan and their Management Evaluation.

Ayesha Tariq1, Imtiaz Majeed, Azhar Khurshid.   

Abstract

Cancer is basically a class of disorder marked by uncontrolled proliferation of cells which have the potential to interfere with different systems of body like digestive, central nervous and circulatory systems by releasing hormones. Tumors that reside only in a specified location and show restricted growth are commonly characterized as benign tumors. When tumor cells grow and effectively spread to other body parts and potentially invade and damage healthy tissues they show various degrees of malignancy. Cancer may be caused by different factors like gene mutations, carcinogens and some medical factors that harm the immune system of the body. Symptoms of cancer are relatively varied and classified according to location, progression pattern and size of tumors as well. Different diagnostic tests are used for evaluation that depends on the type of cancer. Cancer management and chemo protocols also depend on the progression and site where it develops. Cancers like breast, lung, liver, colorectal, prostate, head and neck carcinoma are most commonly diagnosed in Pakistan. This review briefly describes the three most common cancers prevailing in Pakistan and their management evaluation.

Entities:  

Mesh:

Year:  2015        PMID: 25987010     DOI: 10.7314/apjcp.2015.16.9.3605

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Cancer in Lahore, Pakistan, 2010-2019: an incidence study.

Authors:  Farhana Badar; Shahid Mahmood
Journal:  BMJ Open       Date:  2021-08-19       Impact factor: 3.006

2.  Ethnic predisposition, risk factors and breast cancer presentation; a 10-year data. Single centered prospective cohort study from Karachi.

Authors:  Naheed Sultan; Saeed Ahmed Memon; Mehwish Mooghal; Shah Wali; Wajiha Khan; Hina Tahseen; Memuna Khan; Daniyal Monis
Journal:  Ann Med Surg (Lond)       Date:  2022-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.